LTFS
BCDA icon

Ladenburg Thalmann Financial Services’s BioCardia BCDA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BCDA Stock Details BCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$339K Hold
6,149
– – ﹤0.01% 2111
2019
Q3 		$315K Buy
+6,149
New +$441K ﹤0.01% 2128

Other funds holding BCDA

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BCDA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its BioCardia (BCDA) position steady in Q4 2019 at 6,149 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #2111.

Ladenburg Thalmann Financial Services first reported a position in BCDA in Q3 2019 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold BCDA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 6,149 shares of BioCardia worth $339K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its BioCardia share count unchanged in Q4 2019.
  • BioCardia made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2111 holding.
  • Ladenburg Thalmann Financial Services first reported a position in BioCardia in Q3 2019 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held BioCardia as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.